Logo do repositório
 
Publicação

The impact of folic acid supplementation on gestational and long term health: critical temporal windows, benefits and risks

dc.contributor.authorSilva, Carla
dc.contributor.authorKeating, Elisa
dc.contributor.authorPinto, Elisabete
dc.date.accessioned2017-11-14T15:31:06Z
dc.date.available2017-11-14T15:31:06Z
dc.date.issued2017
dc.description.abstractMaternal folic acid (FA) supplementation is one of the most popular nutritional interventions during pregnancy for its protective effect against neural tube defects (NTDs). The purposes of this review are: (a) to gather the current evidence regarding supplementation of maternal diet with FA and (b) to problematize the available literature in terms of dosages, critical temporal windows, and its potential benefits and risks. The expression (pregnancy OR fetus OR offspring OR mother) AND (“folic acid” AND supplementation) was searched on PubMed database, filtering for articles published from 2005 to 2014. Publications referring to FA supplementation during the periconceptional period or pregnancy in which there was a conclusion about the effects of isolated FA supplementation on pregnant woman, pregnancy or offspring were included. Of the initial 1182 papers, 109 fulfilled the inclusion criteria. The majority of the publications reported FA supplementation outcomes on offspring's health, with emphasis in NTDs, allergy/respiratory problems, cancer and behaviour problems. Some inconsistency is observed on the impact of FA supplementation on different outcomes, except for NTDs. It is also visible an increased concern about the impact of excessive supplementation, either in terms of doses or exposure's duration. In conclusion, there is a growing interest in FA supplementation issues. The protective effect of FA supplementation over NTDs has been confirmed, being the periconceptional period a critical window, and it is frequently suggested that allergy/respiratory outcomes arise from (excessive) FA supplementation particularly later in pregnancy. Further research on critical doses and time of exposure should be conducted.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationSilva, C., Keating, E., Pinto, E. (2013). The impact of folic acid supplementation on gestational and long term health: Critical temporal windows, benefits and risks. Porto Biomedical Journal, 2(6), 315-332pt_PT
dc.identifier.doi10.1016/j.pbj.2017.05.006pt_PT
dc.identifier.issn2444-8664
dc.identifier.urihttp://hdl.handle.net/10400.14/23371
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectFolic acidpt_PT
dc.subjectPregnancypt_PT
dc.subjectSupplementationpt_PT
dc.subjectOffspringpt_PT
dc.subjectPericonceptionalpt_PT
dc.titleThe impact of folic acid supplementation on gestational and long term health: critical temporal windows, benefits and riskspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage332
oaire.citation.issue6
oaire.citation.startPage315
oaire.citation.titlePorto Biomedical Journalpt_PT
oaire.citation.volume2
person.familyNameSilva
person.familyNamePinto
person.givenNameCarla
person.givenNameElisabete
person.identifier769375
person.identifier1122670
person.identifier.ciencia-idF418-81A4-F2DA
person.identifier.ciencia-id7616-A133-6144
person.identifier.orcid0000-0002-7509-9135
person.identifier.orcid0000-0001-9028-8009
person.identifier.scopus-author-id56119493700
person.identifier.scopus-author-id35330288600
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationdb3e75ef-4a50-4844-971b-c425bc5b411f
relation.isAuthorOfPublication34b3bd42-53c2-4f5c-8db0-ccd6f2834a74
relation.isAuthorOfPublication.latestForDiscovery34b3bd42-53c2-4f5c-8db0-ccd6f2834a74

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
The impact of folic acid....pdf
Tamanho:
1.37 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
3.44 KB
Formato:
Item-specific license agreed upon to submission
Descrição: